Abstract: The methods of the invention can be used to treat mycobacterial infections, or any disease or disorder that is caused by (or aggravated by) an intracellular pathogen. Accordingly, the invention features methods for treating a subject who has a disorder that is associated with an intracellular pathogen by administering, to a subject, a molecular conjugate that includes a photosensitizer (a term used herein to refer to a light activatable compound) and a targeting moiety, the targeting moiety being capable of targeting the conjugate to the intracellular pathogen.
Type:
Grant
Filed:
October 15, 1999
Date of Patent:
August 26, 2003
Assignee:
The General Hospital Corporation
Inventors:
Tayyaba Hasan, Jerome Gross, Gerard J. Nau
Abstract: Disclosed and claimed is bone or bone tissue supplemented with a therapeutically effective compound and methods for supplementing bone or bone tissue with the therapeutically effective compound.
Type:
Grant
Filed:
June 15, 2000
Date of Patent:
August 5, 2003
Assignee:
The University of Western Australia
Inventors:
Robert Edward Day, Stephen Manfred Megson, David John Wood
Abstract: Disclosed and claimed is a laminar structure. The laminar structure has multiple layers. Each layer has tissue and vasculature. The layers are abjacent. The vasculature is in three dimensions through the structure. The structure has connections for flow into and out of the vasculature. The structure can be implanted directly by connecting blood vessels to flow into and out of the vasculature.